CN1125444A - 新型的二氮杂萘衍生物,它们的制备方法和含有它们的尤其用作抗增生药的药物组合物 - Google Patents

新型的二氮杂萘衍生物,它们的制备方法和含有它们的尤其用作抗增生药的药物组合物 Download PDF

Info

Publication number
CN1125444A
CN1125444A CN94192513A CN94192513A CN1125444A CN 1125444 A CN1125444 A CN 1125444A CN 94192513 A CN94192513 A CN 94192513A CN 94192513 A CN94192513 A CN 94192513A CN 1125444 A CN1125444 A CN 1125444A
Authority
CN
China
Prior art keywords
structural formula
group
dihydro
oxo
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94192513A
Other languages
English (en)
Chinese (zh)
Inventor
N·布鲁-迈尼兹
M·劳那
J·M·特尤隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UPSA SAS
Original Assignee
UPSA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UPSA SAS filed Critical UPSA SAS
Publication of CN1125444A publication Critical patent/CN1125444A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN94192513A 1993-06-25 1994-06-24 新型的二氮杂萘衍生物,它们的制备方法和含有它们的尤其用作抗增生药的药物组合物 Pending CN1125444A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR93/07746 1993-06-25
FR9307746A FR2706898B1 (https=) 1993-06-25 1993-06-25

Publications (1)

Publication Number Publication Date
CN1125444A true CN1125444A (zh) 1996-06-26

Family

ID=9448553

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192513A Pending CN1125444A (zh) 1993-06-25 1994-06-24 新型的二氮杂萘衍生物,它们的制备方法和含有它们的尤其用作抗增生药的药物组合物

Country Status (14)

Country Link
US (1) US5364860A (https=)
EP (1) EP0705261A1 (https=)
JP (1) JPH08511793A (https=)
CN (1) CN1125444A (https=)
AU (1) AU7127594A (https=)
CA (1) CA2161436A1 (https=)
CZ (1) CZ337295A3 (https=)
EE (1) EE9400439A (https=)
FI (1) FI954982A7 (https=)
FR (1) FR2706898B1 (https=)
HU (1) HUT74162A (https=)
MD (1) MD457G2 (https=)
NZ (1) NZ268383A (https=)
SK (1) SK155395A3 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
EP0913392B1 (en) * 1996-04-25 2003-07-02 Nissan Chemical Industries, Limited Ethylene derivatives and pest controlling agents
US6150359A (en) * 1997-08-20 2000-11-21 Warner-Lambert Company Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
AU2017232476B2 (en) * 2016-03-15 2019-10-03 Shionogi & Co., Ltd. Method for producing phenoxyethanol derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
NZ218773A (en) * 1986-01-06 1990-05-28 Carpibem 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.

Also Published As

Publication number Publication date
NZ268383A (en) 1997-03-24
CA2161436A1 (en) 1995-01-05
MD457F1 (en) 1996-08-30
MD457G2 (ro) 1997-04-30
FI954982A0 (fi) 1995-10-19
FI954982L (fi) 1995-12-27
FR2706898B1 (https=) 1995-09-08
SK155395A3 (en) 1996-09-04
US5364860A (en) 1994-11-15
FI954982A7 (fi) 1995-12-27
HU9503776D0 (en) 1996-02-28
EP0705261A1 (fr) 1996-04-10
HUT74162A (en) 1996-11-28
EE9400439A (et) 1996-06-17
JPH08511793A (ja) 1996-12-10
FR2706898A1 (https=) 1994-12-30
CZ337295A3 (en) 1996-03-13
AU7127594A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
CN1138774C (zh) 取代的6,6-杂-双环衍生物
CN1041203C (zh) 吡唑并吡啶化合物的制备方法
CN1149252A (zh) 新的取代的色胺类化合物、苯烷基胺类化合物及同类化合物
CN1129941A (zh) 取代的氮杂二氢亚吲哚基化合物及其制备方法
CN1909897A (zh) 用于治疗阿尔茨海默病的苯基羧化物β-分泌酶抑制剂
CN1348453A (zh) 嘧啶并[6,1-a] 异喹啉-4-酮衍生物
CN1771234A (zh) 吡咯并三嗪激酶抑制剂的制备方法
CN1340044A (zh) 莫维诺林衍生物
CN1440399A (zh) 具comt抑制活性的香豆素衍生物
CN1440398A (zh) 用作抗惊厥药的取代2-苯并[c]呋喃酮
CN1297887A (zh) 制备吡啶衍生物的方法
CN1095836C (zh) 苯并咪唑衍生物
CN1097006A (zh) O-芳基吗啡喃的醚类化合物
CN1258277A (zh) 细胞增生抑制剂氰基胍
CN1956962A (zh) 四氢异喹啉磺酰胺衍生物,其制备方法及其在治疗中的应用
HK1044934A1 (en) Amide compounds for the potentiation of cholinergic activity
CN1041088C (zh) 光学活性咪唑烷酮衍生物和抗痴呆药物组合物
CN1125444A (zh) 新型的二氮杂萘衍生物,它们的制备方法和含有它们的尤其用作抗增生药的药物组合物
CN1064075A (zh) 氨基甲酸衍生物及其制备方法
CN1097005A (zh) 2-氰基-3-羟基丙烯酰胺类化合物及其制备和用途
CN1159806A (zh) 咪唑并吡啶-吡咯烷酮和咪唑并吡啶-噁唑烷酮
CN1738808A (zh) 取代的苯并噻唑衍生物的环化方法
CN1255131A (zh) 作为氧化氮合酶抑制剂的脒衍生物
CN1258278A (zh) 作为细胞增殖抑制剂的氰基胍
CN1374951A (zh) 4(5)-氨基-5(4)-氨基甲酰基咪唑及其中间体的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication